Equity Analyst Upgrades and Downgrades You Must Know

Wall St. Watchdog reveals information about companies for which stock analysts either upgraded or downgraded the shares on May 4th.

Upgrades

Sally Beauty (NYSE:SBH):

Barclays upgraded its rating on this company from Equal Weight to Overweight and changed its price target from $21 to $32.

RenaissanceRe (NYSE:RNR):

Barclays upgraded its rating on this company from Equal Weight to Overweight and changed its price target from $85 to $95.

Allstate (NYSE:ALL):

Barclays upgraded its rating on this company from Equal Weight to Overweight and changed its price target from $38 to $39.

GeoEye (NASDAQ:GEOY):

The Benchmark Company upgraded its rating on this company from Hold to Buy and changed its price target to $30.

Ballard Power (NASDAQ:BLDP):

Ardour Capital upgraded its rating on this company from Hold to Accumulate and changed its price target from $1.75 to $1.5.

EnerNOC (NASDAQ:ENOC):

Ardour Capital upgraded its rating on this company from Hold to Accumulate and changed its price target from $10 to $7.5.

Houston American Energy (NYSE:HUSA):

C.K. Cooper upgraded its rating on this company from Hold to Buy and changed its price target to $4.

Atlas Air Worldwide (NASDAQ:AAWW):

Maxim Group upgraded its rating on this company from Hold to Buy and changed its price target to $65.

Parkway Prop (NYSE:PKY):

Stifel Nicolaus upgraded its rating on this company from Hold to Buy and changed its price target to $11.5.

Mohawk (NYSE:MHK):

Stifel Nicolaus upgraded its rating on this company from Hold to Buy and changed its price target to $84.

Constant Contact (NASDAQ:CTCT):

Stifel Nicolaus upgraded its rating on this company from Hold to Buy and changed its price target to $33.

Multi-Fineline (NASDAQ:MFLX):

Needham upgraded its rating on this company from Hold to Buy and changed its price target to $27.

AMN Healthcare Services (NYSE:AHS):

Robert W. Baird upgraded its rating on this company from Neutral to Outperform and changed its price target from $6 to $9.

Downgrades

Prudential (NYSE:PRU):

Barclays downgraded its rating on this company from Overweight to Equal Weight and changed its price target from $69 to $62.

MEDNAX (NYSE:MD):

Deutsche Bank downgraded its rating on this company from Buy to Hold and changed its price target from $81 to $73.

Bemis (NYSE:BMS):

Longbow downgraded its rating on this company from Neutral to Sell and changed its price target to $25.

Two Harbors Investment (AMEX:TWO):

Ladenburg Thalmann downgraded its rating on this company from Buy to Neutral.

BioMed Realty (NYSE:BMR):

Stifel Nicolaus downgraded its rating on this company from Buy to Hold.

Gen-Probe (NASDAQ:GPRO):

Robert W. Baird downgraded its rating on this company from Outperform to Neutral and changed its price target to $83.

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.